Anti-breast cancer-induced cardiomyopathy: Mechanisms and future directions-Reference-Cited by-同舟云学术

Anti-breast cancer-induced cardiomyopathy: Mechanisms and future directions

Published:2023-10 Issue: Volume:166 Page:115373
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Liu Chunping,Chen Huiqi,Guo Sien,Liu Qiaojing,Chen Zhijun,Huang Haiding,Zhao Qi,Li Longmei,Cen Huan,Jiang Zebo,Luo Qiyuan,Chen Xiaoling,Zhao Jiaxiong,Chen Wensheng,Yang Phillip C.,Wang Lei

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference127 articles.

1. Cardiotoxicity of contemporary breast cancer treatments;Lee Chuy;Curr. Treat. Options Oncol.,2019

2. Cardiotoxicity of cancer chemotherapy in clinical practice;Jain;Hosp. Pr.,1995

3. Breast cancer statistics, 2022;Giaquinto;CA Cancer J. Clin.,2022

4. A population-based study of cardiovascular disease mortality risk in US cancer patients;Sturgeon;Eur. Heart J.,2019

5. Anthracyclines in the treatment of early breast cancer friend or foe?;Vuger;Breast,2022

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis and anti-breast cancer evaluation of fused imidazole-imidazo[1,2-c][1,2,3]triazoles: PEG-400 mediated one-pot reaction under ultrasonic irradiation;Journal of Molecular Structure;2024-09

2. Design and synthesis of Lanthanide(III) complex based luminescence probes for time-resolved luminescence detection of β-galactosidase;Journal of Luminescence;2024-08

3. Synthesis of [1,2,4]triazolo[3,4-b][1,3,4]thiadiazine-1,2,3-triazoles as potent EGFR targeting anti-breast cancer agents;Journal of Molecular Structure;2024-06

4. Synthesis, Anti-Breast Cancer, and EGFR Activity of Novel Pyrido[2,3-d]pyrimidine-piperazine-1,2,4-oxadiazoles;Russian Journal of General Chemistry;2024-06

5. Cardiovascular events associated with CDK4/6 inhibitors based on randomized controlled trials or cohort trials: a safety meta-analysis;2024-04-04